131 related articles for article (PubMed ID: 25363729)
1. Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid.
Kong J; Xu B; Wei W; Wang X; Xie W; Yu XF
Protein Cell; 2014 Dec; 5(12):954-7. PubMed ID: 25363729
[No Abstract] [Full Text] [Related]
2. Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.
Buffone C; Schulte B; Opp S; Diaz-Griffero F
J Virol; 2015 Mar; 89(6):3285-94. PubMed ID: 25568212
[TBL] [Abstract][Full Text] [Related]
3. MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid.
Smaga SS; Xu C; Summers BJ; Digianantonio KM; Perilla JR; Xiong Y
Structure; 2019 Aug; 27(8):1234-1245.e5. PubMed ID: 31155311
[TBL] [Abstract][Full Text] [Related]
4. Binding of host factors to stabilized HIV-1 capsid tubes.
Selyutina A; Bulnes-Ramos A; Diaz-Griffero F
Virology; 2018 Oct; 523():1-5. PubMed ID: 30056211
[TBL] [Abstract][Full Text] [Related]
5. Mx oligomer: a novel capsid pattern sensor?
Kong J; Ma M; He S; Qin X
Future Microbiol; 2016 Aug; 11():1047-55. PubMed ID: 27492442
[TBL] [Abstract][Full Text] [Related]
6. Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.
Schulte B; Buffone C; Opp S; Di Nunzio F; De Souza Aranha Vieira DA; Brandariz-Nuñez A; Diaz-Griffero F
J Virol; 2015 Aug; 89(16):8599-610. PubMed ID: 26063425
[TBL] [Abstract][Full Text] [Related]
7. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
[TBL] [Abstract][Full Text] [Related]
8. The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction.
Betancor G; Dicks MDJ; Jimenez-Guardeño JM; Ali NH; Apolonia L; Malim MH
Cell Rep; 2019 Nov; 29(7):1923-1933.e3. PubMed ID: 31722207
[TBL] [Abstract][Full Text] [Related]
9. The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB.
Liu Z; Pan Q; Liang Z; Qiao W; Cen S; Liang C
Retrovirology; 2015 Jan; 12():1. PubMed ID: 25571928
[TBL] [Abstract][Full Text] [Related]
10. Structural insight into the assembly of human anti-HIV dynamin-like protein MxB/Mx2.
Xu B; Kong J; Wang X; Wei W; Xie W; Yu XF
Biochem Biophys Res Commun; 2015 Jan; 456(1):197-201. PubMed ID: 25446123
[TBL] [Abstract][Full Text] [Related]
11. Structural insight into HIV-1 restriction by MxB.
Fribourgh JL; Nguyen HC; Matreyek KA; Alvarez FJD; Summers BJ; Dewdney TG; Aiken C; Zhang P; Engelman A; Xiong Y
Cell Host Microbe; 2014 Nov; 16(5):627-638. PubMed ID: 25312384
[TBL] [Abstract][Full Text] [Related]
12. Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.
Staeheli P; Haller O
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258007
[TBL] [Abstract][Full Text] [Related]
13. MX2-mediated innate immunity against HIV-1 is regulated by serine phosphorylation.
Betancor G; Jimenez-Guardeño JM; Lynham S; Antrobus R; Khan H; Sobala A; Dicks MDJ; Malim MH
Nat Microbiol; 2021 Aug; 6(8):1031-1042. PubMed ID: 34282309
[TBL] [Abstract][Full Text] [Related]
14. MxB sensitivity of HIV-1 is determined by a highly variable and dynamic capsid surface.
Miles RJ; Kerridge C; Hilditch L; Monit C; Jacques DA; Towers GJ
Elife; 2020 Jun; 9():. PubMed ID: 32553106
[TBL] [Abstract][Full Text] [Related]
15. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1.
Fricke T; White TE; Schulte B; de Souza Aranha Vieira DA; Dharan A; Campbell EM; Brandariz-Nuñez A; Diaz-Griffero F
Retrovirology; 2014 Aug; 11():68. PubMed ID: 25123063
[TBL] [Abstract][Full Text] [Related]
16. Host and viral determinants of Mx2 antiretroviral activity.
Busnadiego I; Kane M; Rihn SJ; Preugschas HF; Hughes J; Blanco-Melo D; Strouvelle VP; Zang TM; Willett BJ; Boutell C; Bieniasz PD; Wilson SJ
J Virol; 2014 Jul; 88(14):7738-52. PubMed ID: 24760893
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein.
Cornilescu CC; Bouamr F; Yao X; Carter C; Tjandra N
J Mol Biol; 2001 Mar; 306(4):783-97. PubMed ID: 11243788
[TBL] [Abstract][Full Text] [Related]
18. GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.
Xie L; Ju Z; Zhong C; Wu Y; Zan Y; Hou W; Feng Y
Virol Sin; 2021 Feb; 36(1):85-94. PubMed ID: 32632818
[TBL] [Abstract][Full Text] [Related]
19. CryoEM structure of MxB reveals a novel oligomerization interface critical for HIV restriction.
Alvarez FJD; He S; Perilla JR; Jang S; Schulten K; Engelman AN; Scheres SHW; Zhang P
Sci Adv; 2017 Sep; 3(9):e1701264. PubMed ID: 28929138
[TBL] [Abstract][Full Text] [Related]
20. Host and viral determinants for MxB restriction of HIV-1 infection.
Matreyek KA; Wang W; Serrao E; Singh PK; Levin HL; Engelman A
Retrovirology; 2014 Oct; 11():90. PubMed ID: 25348155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
